A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 564-569

  Takata, Akemi ^a   Otsuka, Motoyuki ^a   Yoshikawa, Takeshi ^a   Kishikawa, Takahiro ^a   Kudo, Yotaro ^a   Goto, Tadashi ^a   Yoshida, Haruhiko ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

DDX20; MicroRNA; NF B

Indexed keywords

DEAD BOX PROTEIN 20; I KAPPA B; I KAPPA B ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 140; PROTEIN P50; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENOMICS; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DEAD BOX PROTEIN 20; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; MICRORNAS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859611110     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.034     Document Type: Article

References (32)

1. Parkin D., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer. J. Clin. 2005, 55:74-108.
2. El-Serag H. Epidemiology of hepatocellular carcinoma in USA. Hepatol. Res. 2007, 37(Suppl.2):S88-94.
3. Llovet J., Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008, 48:1312-1327.
4. Llovet J., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J., de Oliveira A., Santoro A., Raoul J., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T., Galle P., Seitz J., Borbath I., Häussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J., Group S.I.S. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 2008, 359:378-390.
5. Voss M., Hille A., Barth S., Spurk A., Hennrich F., Holzer D., Mueller-Lantzsch N., Kremmer E., Grässer F. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. J. Virol. 2001, 75:11781-11790.
6. Charroux B., Pellizzoni L., Perkinson R., Shevchenko A., Mann M., Dreyfuss G. Gemin3: a novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J. Cell. Biol. 1999, 147:1181-1194.
7. Ou Q., Mouillet J., Yan X., Dorn C., Crawford P., Sadovsky Y. The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Mol. Endocrinol. 2001, 15:69-79.
8. Klappacher G., Lunyak V., Sykes D., Sawka-Verhelle D., Sage J., Brard G., Ngo S., Gangadharan D., Jacks T., Kamps M., Rose D., Rosenfeld M., Glass C. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 2002, 109:169-180.
9. Gillian A., Svaren J. The Ddx20/DP103 dead box protein represses transcriptional activation by Egr2/Krox-20. J. Biol. Chem. 2004, 279:9056-9063.
10. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., Rappsilber J., Mann M., Dreyfuss G. MiRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002, 16:720-728.
11. Hutvágner G., Zamore P. A MicroRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
12. Mouillet J., Yan X., Ou Q., Jin L., Muglia L., Crawford P., Sadovsky Y. DEAD-box protein-103 (DP103, Ddx20) is essential for early embryonic development and modulates ovarian morphology and function. Endocrinology 2008, 149:2168-2175.
13. Zender L., Xue W., Zuber J., Semighini C., Krasnitz A., Ma B., Zender P., Kubicka S., Luk J., Schirmacher P., McCombie W., Wigler M., Hicks J., Hannon G., Powers S., Lowe S. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008, 135:852-864.
14. Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R., Das S.C., Pattnaik A.K., Beutler B., Han J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
15. Otsuka M., Takata A., Yoshikawa T., Kojima K., Kishikawa T., Shibata C., Takekawa M., Yoshida H., Omata M., Koike K. Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma. PLoS One 2011, 6:e24359.
16. Otsuka M., Kato N., Lan K., Yoshida H., Kato J., Goto T., Shiratori Y., Omata M. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 2000, 275:34122-34130.
17. Miyagawa J., Muguruma M., Aoto H., Suetake I., Nakamura M., Tajima S. Isolation of the novel cDNA of a gene of which expression is induced by a demethylating stimulus. Gene 1999, 289-295.
18. Schreiber E., Matthias P., Müller M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989, 17:6419.
19. Fuller-Pace F., Jacobs A., Nicol S. Modulation of transcriptional activity of the DEAD-box family of RNA helicases, p68 (Ddx5) and DP103 (Ddx20), by SUMO modification. Biochem. Soc. Trans. 2007, 35:1427-1429.
20. Luedde T., Schwabe R.F. NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:108-118.
21. Arsura M., Cavin L. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett. 2005, 229:157-169.
22. Pikarsky E., Porat R., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
23. Tai D., Tsai S., Chang Y., Huang S., Chen T., Chang K., Liaw Y. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000, 89:2274-2281.
24. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 1990, 265:21128-21133.
25. Takata A., Otsuka M., Kojima K., Yoshikawa T., Kishikawa T., Yoshida H., Koike K. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators. Biochem. Biophys. Res. Commun. 2011, 411:826-831.
26. Block T., Mehta A., Fimmel C., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
27. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
28. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., Ambs S., Chen Y., Meltzer P., Croce C., Qin L., Man K., Lo C., Lee J., Ng I., Fan J., Tang Z., Sun H., Wang X. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 2009, 361:1437-1447.
29. Kojima K., Takata A., Vadnais C., Otsuka M., Yoshikawa T., Akanuma M., Kondo Y., Kang Y.J., Kishikawa T., Kato N., Xie Z., Zhang W.J., Yoshida H., Omata M., Nepveu A., Koike K. MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat. Commun. 2011, 2:338.
30. Kumar M.S., Lu J., Mercer K.L., Golub T.R., Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 2007, 39:673-677.
31. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
32. Martello G., Rosato A., Ferrari F., Manfrin A., Cordenonsi M., Dupont S., Enzo E., Guzzardo V., Rondina M., Spruce T., Parenti A., Daidone M., Bicciato S., Piccolo S. A MicroRNA targeting dicer for metastasis control. Cell 2010, 141:1195-1207.